Related Experiment Video
Updated: May 14, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Proposal of stability categories for nano-dispersions obtained from pharmaceutical self-emulsifying formulations
Andreas Niederquell1, Martin Kuentz
1University of Applied Sciences and Arts Northwestern Switzerland, Institute of Pharmaceutical Technology, Gründenstr. 40, CH-4132 Muttenz, Switzerland.
Abstract:
Lipid-based formulations that disperse in water as nano-droplets are of considerable pharmaceutical interest. However, there is a recent debate on which systems form stable swollen micelles rather than other thermodynamically unstable nano-emulsions. This study introduces stability categories for nano-dispersions by considering theoretical arguments of particle size and polydispersity. In a second step, 20 pharmaceutical nano-emulsifying formulations were investigated with respect to the physical stability of the aqueous dispersions. Thermo-reversibility was studied using dynamic laser light scattering, ultrasonic resonator technology and near-infrared (NIR) analytical centrifugation. As a result, the majority of the dispersions were indeed nano-emulsions that exhibited only kinetic stability. Dispersions that were stable following the heat stress test were then further evaluated with respect to an alternative compounding other than dilution from a preconcentrate. Seven dispersions were hereafter deemed to be stable in the thermodynamic sense because they exhibited the same light scattering results independent of their compounding method. In conclusion, the proposed stability categories were shown to successfully assign dispersions. This has a general importance and can, for example, be applied when nano-dispersions are used as pre-clinical formulations.
Related Concept Videos
The Colloidal State
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Bioavailability Enhancement: Drug Solubility Enhancement
